Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Irinotecan × CNS × Clear all

Phase

Status

Completed 56 Terminated 13 Recruiting 12 Active not recruiting 8 Unknown 5 Withdrawn 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 25 Thoracic 2 Sarcoma 1 Other solid neoplasm 1 CNS 1

Conditions

Medulloblastoma 1

Interventions

Temozolomide 17 Magnetic Resonance Spectroscopy 8 Blood Specimen Collection 8 Radiotherapy 7 Cyclophosphamide 6 Bevacizumab 6 AZD 6244 6 pembrolizumab 5 aflutinib 4 fludarabine 3 Specimen Handling 3 Radiation 3 Biopsy 3 vorasidenib 2 tovorafenib 2 tislelizumab 2 fludarabine phosphate 2 dinutuximab 2 Topotecan 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Pemetrexed 2 Nivolumab 2 Lomustine 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Craniotomy 2 Anthropogenic Effects 2 Aminolevulinic Acid 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346157 2026-01-16

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡